Grady, Denise. "Tracing Crucial Components
of Meningitis Outbreak." The New York Times. The New York
Times, 16 Oct. 2012. Web. 18 Oct. 2012. <http://www.nytimes.com/2012/10/16/health/tracing-crucial-components-of-meningitis-outbreak.html?ref=science>.
This article describes the
meningitis outbreak across the country caused by contaminated treatments for
spine and neck problems. The fungus causes a severe form of meningitis that can
cause strokes and has resulted in now 19 deaths (the article, written two days
ago, says 14), and 205 severe cases. It is estimated that 14,000 people have
come in contact with the fungus. The fungus is called Exserohilum, one so rare
that most doctors have never heard of it. The treatment that is contaminated is
called methylprednisolone, and a total of 17,676 vials of it are involved
in the outbreak. Though several patients have experienced symptoms, there are
several more who have not gotten sick (some doctors estimate that the
proportion may be as low as 5 percent). Doctors are now trying to find out why some
people have been killed while others have gone symptom-free.
Figuring out why some people are
contaminated could have several positive implications on the science of
administering drugs to the spine. There are a number of possible explanations
for why some people get sick, relating to variations in the extent of
contamination, the patients’ underlying health, and the procedure itself. As
most of the patients had strong immune systems, doctors are led to believe that
it is due to bad procedures on behalf of the doctors. The injection used to
administer the drug should not pierce the Dura, one of the membranes that cover
the spinal cord and brain. As most doctors do not use fluoroscopy to help
them guide the needle, the contamination may be due to nicks in the Dura. This
would allow the fungus to enter into the spinal fluids, and consequently, the
brain. More research by specialists could help determine what physicians could
improve when administering drugs, and could lead to better safety procedures in
the field.
I believe that the author could have
done a better job organizing the article and explaining the effects of the
fungus. She often went back to previous arguments, and sometimes her
progression of ideas was confusing. She also didn’t explain how the fungus
killed patients; she only explained what it was. She did do a good job
explaining what could have caused the fungus to enter the spinal fluids and the
controversy surrounding safety regulations in administering these drugs.